February 7, 2025
Point-of-Care Diagnostic for Trichomonas Vaginalis Based on MedMira’s RVF Technology(R)

HALIFAX, NS / ACCESSWIRE / January 3, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the publication of Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually Transmitted Infection – (available: https://www.mdpi.com/2076-0817/12/1/77), in the special edition of Pathogens by MDPI, a Swiss based medical journal…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *